Showing results (301-310 of 407) with videos related to
Sort By:
Pageof 41
Parkinsonism & Related Disorders|April 28, 2023
Variants in PSMB9 and FGR differentially affect Parkinson's disease risk in GBA and LRRK2 mutation carriersShachar Shani, Orly Goldstein, Mali Gana-Weisz, et al.Journal of Neurology|March 28, 2025
The effects of dopaminergic medication and task load on trembling and akinetic freezing of gait in Parkinson's diseaseDemi Zoetewei, Pieter Ginis, Talia Herman, et al.Neurology|February 6, 2015
Differential effects of severe vs mild GBA mutations on Parkinson diseaseZiv Gan-Or, Idan Amshalom, Laura L Kilarski, et al.The Lancet. Neurology|April 13, 2019
Gait impairments in Parkinson's diseaseAnat Mirelman, Paolo Bonato, Richard Camicioli, et al.JAMA Neurology|October 11, 2016
High Frequency of GBA Gene Mutations in Dementia With Lewy Bodies Among Ashkenazi JewsTamara Shiner, Anat Mirelman, Mali Gana Weisz, et al.Movement Disorders : Official Journal of the Movement Disorder Society|October 15, 2013
Fall risk and gait in Parkinson's disease: the role of the LRRK2 G2019S mutationAnat Mirelman, Talia Heman, Kira Yasinovsky, et al.Physical Therapy|May 3, 2014
Clinical experience using a 5-week treadmill training program with virtual reality to enhance gait in an ambulatory physical therapy serviceShirley Roth Shema, Marina Brozgol, Moran Dorfman, et al.Gait & Posture|April 8, 2018
Treadmill walking reduces pre-frontal activation in patients with Parkinson's diseasePablo Cornejo Thumm, Inbal Maidan, Marina Brozgol, et al.The Lancet. Neurology|December 16, 2014
Efficacy of rasagiline in patients with the parkinsonian variant of multiple system atrophy: a randomised, placebo-controlled trialWerner Poewe, Klaus Seppi, Cheryl J Fitzer-Attas, et al.Plos One|April 14, 2017
DaT-SPECT assessment depicts dopamine depletion among asymptomatic G2019S LRRK2 mutation carriersMoran Artzi, Einat Even-Sapir, Hedva Lerman Shacham, et al.Pageof 41